» Articles » PMID: 20057008

Validation of a New Grid-based Boltzmann Equation Solver for Dose Calculation in Radiotherapy with Photon Beams

Overview
Journal Phys Med Biol
Publisher IOP Publishing
Date 2010 Jan 9
PMID 20057008
Citations 107
Authors
Affiliations
Soon will be listed here.
Abstract

A new grid-based Boltzmann equation solver, Acuros, was developed specifically for performing accurate and rapid radiotherapy dose calculations. In this study we benchmarked its performance against Monte Carlo for 6 and 18 MV photon beams in heterogeneous media. Acuros solves the coupled Boltzmann transport equations for neutral and charged particles on a locally adaptive Cartesian grid. The Acuros solver is an optimized rewrite of the general purpose Attila software, and for comparable accuracy levels, it is roughly an order of magnitude faster than Attila. Comparisons were made between Monte Carlo (EGSnrc) and Acuros for 6 and 18 MV photon beams impinging on a slab phantom comprising tissue, bone and lung materials. To provide an accurate reference solution, Monte Carlo simulations were run to a tight statistical uncertainty (sigma approximately 0.1%) and fine resolution (1-2 mm). Acuros results were output on a 2 mm cubic voxel grid encompassing the entire phantom. Comparisons were also made for a breast treatment plan on an anthropomorphic phantom. For the slab phantom in regions where the dose exceeded 10% of the maximum dose, agreement between Acuros and Monte Carlo was within 2% of the local dose or 1 mm distance to agreement. For the breast case, agreement was within 2% of local dose or 2 mm distance to agreement in 99.9% of voxels where the dose exceeded 10% of the prescription dose. Elsewhere, in low dose regions, agreement for all cases was within 1% of the maximum dose. Since all Acuros calculations required less than 5 min on a dual-core two-processor workstation, it is efficient enough for routine clinical use. Additionally, since Acuros calculation times are only weakly dependent on the number of beams, Acuros may ideally be suited to arc therapies, where current clinical algorithms may incur long calculation times.

Citing Articles

Dummy run study for outlining and plan quality of intensity-modulated radiotherapy in elderly patients with newly diagnosed glioblastoma: The Japan clinical oncology group study JCOG1910 (AgedGlio-PIII).

Ono T, Uto M, Mineharu Y, Arakawa Y, Nakamura M, Nishio T Radiat Oncol. 2025; 20(1):32.

PMID: 40059195 PMC: 11890525. DOI: 10.1186/s13014-025-02612-z.


Automated hippocampal sparing whole brain radiotherapy with simultaneous integrated boost for multiple brain metastases: Halcyon, HyperArc on TrueBeam, and coplanar TrueBeam.

McCarthy S, Clark R, Magliari A, Clair W, Pokhrel D J Appl Clin Med Phys. 2024; 26(2):e14570.

PMID: 39611851 PMC: 11799903. DOI: 10.1002/acm2.14570.


Quantification of uncertainties in reference and relative dose measurements, dose calculations, and patient setup in modern external beam radiotherapy.

Kinoshita N, Shimizu M, Motegi K, Tsuruta Y, Takakura T, Oguchi H Radiol Phys Technol. 2024; 18(1):58-77.

PMID: 39541009 PMC: 11876197. DOI: 10.1007/s12194-024-00856-0.


Replacing manual planning with automatic iterative planning for locally advanced rectal cancer VMAT treatment.

Liu J, Wang R, Wang Q, Yao K, Wang M, Du Y J Appl Clin Med Phys. 2024; 26(1):e14552.

PMID: 39406255 PMC: 11713272. DOI: 10.1002/acm2.14552.


Retrospective assessment of HDR brachytherapy dose calculation methods in locally advanced cervical cancer patients: AcurosBV vs. AAPM TG43 formalism.

Radcliffe B, Kim Y, Raffi J, Ayala-Peacock D, Stephens S, Chino J J Appl Clin Med Phys. 2024; 26(1):e14549.

PMID: 39382834 PMC: 11712453. DOI: 10.1002/acm2.14549.